Top Story

Nexavar prolongs survival for patients with HCC, extrahepatic spread

May 4, 2015

Nexavar monotherapy prolonged survival in patients with hepatocellular carcinoma with extrahepatic spread who achieved disease control, according to findings published in the Journal of Hepatology.

Researchers from Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, South Korea, analyzed data from 254 patients with HCC and extrahepatic spread (EHS) who were treated with Nexavar (sorafenib, Bayer Healthcare) monotherapy for a minimum of 8 weeks. The goal of the research was to determine outcomes and prognostic factors of sorafenib treatment in this patient population.

Thomas A. Gustafson, PhD Health Care Legislative and Regulatory Update

Are you in an Alternative Payment Model? Why it matters

May 4, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the JournalsPerspective

Laparoscopic radical cystectomy conferred favorable long-term survival outcomes

May 4, 2015
Patients with muscle-invasive or high-risk bladder cancer experienced favorable RFS, OS and cancer-specific survival outcomes after undergoing laparoscopic radical…
In the Journals

Older patients, women face greater risk for emergency cancer diagnosis

May 4, 2015
Older individuals were at an increased risk for the diagnosis of lung and colorectal cancers during emergency presentation, according to results of a literature…
Scott Nicholas Gettinger, MD In the Journals

Nivolumab monotherapy displays efficacy in previously treated NSCLC

May 4, 2015
Nivolumab conferred durable responses and prolonged OS in patients with previously treated non–small cell lung cancer, according to study results.“Progress…
More News Headlines »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
VIDEO: MPDL3280A demonstrates safety, efficacy for patients with metastatic triple-negative breast cancer

VIDEO: MPDL3280A demonstrates safety, efficacy for patients with metastatic triple-negative breast cancer

April 30, 2015
Leisha A. Emens, MD, associate professor of oncology at The Johns Hopkins University School of Medicine and the Sidney…
More »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
morganatic-roan